Authors

Kenneth Bender, PharmD, MA
Latest Article

The “Grave Threat” Posed by the Shortage of Neurologists

With the physician deficit projected to grow larger within a decade, this global challenge has become a major focus of large organizations and medical societies.

Rod Foroozan, MD
Ashley Aaroe, MD
Latest Article

Neurology on the Hill: My Role as an Advocate for Neurology

Neuro-oncology fellow Ashley Aaroe recounts her experience at Neurology on the Hill, advocating for important changes in neurology health care.

Rodney A. Radtke, MD
Erica Slaughter, MS
Latest Article

Managing Psychosis in Parkinson Disease: Challenges and Opportunities

Although the indication of pimavanserin has provided some relief, more work remains to improve how physicians diagnose, treat, and manage psychosis symptoms.

Suhayl Dhib-Jalbut, MD

Chief of Neurology at Robert Wood Johnson University Hospital and Chair of Neurology at Rutgers Robert Wood Johnson Medical School and Rutgers Medical School of New Jersey in New Brunswick.

Latest Article

Study Findings Provide New Hope for Patients With Multiple Sclerosis

Multiple sclerosis affects nearly 3 million patients worldwide; new research is helping pave the way for developing new therapies and medications that get at the defining mechanisms that trigger immune regulation loss of this unpredictable central nervous system disease.

Matthew J. Baker, MD
James W. Kupiec, MD
Latest Article

Aducanumab's Unlikely Road to the FDA: Is Approval Imminent?

Recent news that the FDA has granted the fastest possible review for Biogen’s Alzheimer disease treatment aducanumab may be indicative of the agency’s increasing confidence in the drug.

David Bai, PharmD
Latest Article

What You Need to Know About Amantadine for Parkinson Disease

This guide includes everything you need to know about amantadine (Osmolex ER, Osmotica Pharmaceuticals) for the treatment of Parkinson disease and drug-induced extrapyramidal reactions in adults.

Eveline Honig, MD, MPH
Peter LeWitt, MD, M.Med.Sc
Will Pass, DVM
Latest Article

Sigma-1 Agonists Offer Combination Approach to Dementia Symptoms

Research from the past decade suggests that sigma-1 receptors and their encoding gene, SIGMAR1, together act as a therapeutic target for patients with dementia.

Krithika Subramanian, PhD
Latest Article

Targeting the NF-kB Pathway in Duchenne Muscular Dystrophy

An in-depth analysis of the genetics of DMD and disease modifiers such as the NF-kB pathway in patients with Duchenne muscular dystrophy.

Jeffrey Kaplan, MD
Akshay Desai, MD, MPH
Erin M. Burns, PhD, MSPH
Latest Article

Targeting the Neonatal Fc Receptor in Myasthenia Gravis

Understanding the pathophysiology of myasthenia gravis is still being determined to this day, but the neonatal Fc receptor is emerging as a potential treatment.

Mary Curry, ND
Latest Article

Spinal Muscular Atrophy and COVID-19: Guidance and Resources for Providers

Advocacy organization Cure SMA provides guidance for health care providers caring for patients with SMA during the ongoing COVID-19 pandemic.

Yasir Al-Khalili, MD
Latest Article

The Challenges of Stroke Care in Rural America

Stroke care, including acute treatment and prevention, faces unique challenges in rural areas where disease awareness is lacking and access to high-level care in scarce.

Whitney Palmer
Latest Article

Neurologic Complications of COVID-19 Reported

The first presumptive case of acute necrotizing encephalopathy in a patient with confirmed COVID-19 has been published in the journal Radiology.

Hannah Kent Ritchie, PhD
Latest Article

COMT Inhibitors Assist in Control of Parkinson Disease Motor Symptoms

More recently, investigators have discovered that catechol-O-methyltransferase inhibitors can prolong the effects of levodopa, thereby limiting the off-time phenomenon.

Krista Rossi
Latest Article

California Startup Exploring Novel ALS Discovery Platform

A grant from the National Institute of Neurological Disorders and Stroke, which allows for concurrent phase I and II trial design review, will speed up the development of novel treatments for patients with ALS and FTD.

Victor Ferastraoaru, MD
Latest Article

EEG Abnormalities in Acutely Ill Patients With COVID-19

Preliminary findings from a retrospective sample series in the Bronx, New York.

Alexis Boro, MD
Latest Article

EEG Abnormalities in Acutely Ill Patients With COVID-19

Preliminary findings from a retrospective sample series in the Bronx, New York.

Jill M. Giordano Farmer, DO, MPH, Rajesh Pahwa, MD, Daniel E. Kremens, MD, JD, Peter LeWitt, MD, M.Med.Sc, Stuart Isaacson, MD
Nicola Davies, PhD
Latest Article

How Big Data Can Drive Advancements in MS Research

Big data is on the precipice of revolutionizing multiple sclerosis knowledge and treatment.

Danielle B. Cross, MD, MS
Latest Article

Everyone Is Working Hard: Why Shift Work Shouldn't Be Celebrated

Danielle B. Cross, MD, MS, a neurology resident in training, shares her thoughts on why glorifying exhaustion is unhealthy.

Jeffrey M. Kaplan, MD
Elizabeth A. Kichula, MD, PhD

Assistant Professor of Clinical Neurology, Perelman School of Medicine, University of Pennsylvania; Attending Physician, Children's Hospital of Philadelphia

Latest Article

Highly Effective Gene Therapies for SMA: Where Do We Go From Here?

Neuromuscular medicine has entered an era of genetic therapy, opening the doors to questions about possible combination approaches and earlier initiation of treatment.

Cecilia Pessoa Gingerich
Latest Article

FDA Grants Alzheimer Biomarker Test Breakthrough Status

The FDA has granted a Breakthrough Device Designation to the Elecsys beta-Amyloid (1-42) and Elecsys Phospho-Tau (181P) cerebrospinal fluid assays, which can be used in the diagnosis of Alzheimer disease.

Kevin McGehrin, MD

The Neuron Clinic, San Diego, California.

Latest Article

Challenges and Opportunities Bringing Lecanemab to Neurology Community Clinics 

A group of experts from The Neuron Clinic shared their experience developing a novel inclusive clinical program to treat patients with early Alzheimer disease using lecanemab.

Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

HCP Live
Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us